Effect of synthesis parameters of the sol-gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine

被引:50
作者
Kortesuo, P
Ahola, M
Kangas, M
Jokinen, M
Leino, T
Vuorilehto, L
Laakso, S
Kiesvaara, J
Yli-Urpo, A
Marvola, M
机构
[1] Orion Corp Farmos, Pharmaceut Dev Dept, FIN-20101 Turku, Finland
[2] Univ Turku, Inst Dent, FIN-20520 Turku, Finland
[3] Univ Helsinki, Dept Pharm, Div Biopharmaceut & Pharmacokinet, FIN-00014 Helsinki, Finland
关键词
silica gel microparticles; spray drying; dexmedetomidine; in vivo;
D O I
10.1016/S0142-9612(02)00016-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The objective of this study was to evaluate the possibilities to control the release rate of dexmedetomidine (DMED) from different spray-dried silica gel microparticle formulations. Microparticles were prepared by spray drying a silica sot polymer solution containing the drug. Drug release was investigated both in vitro and in vivo. The influence of sol-gel synthesis parameters like pH and the water/alkoxide ratio (r) of the sot, on the release behaviour of the drug, vas studied. Silica gel microparticles had a smooth surface. Microparticles prepared from diluted sot, however were more aggregated and clustered. The drug release conformed to zero order release from microparticles prepared near the isoelectric point of silica (pH 2.3 and pH 3) and to the square root of time kinetics from microparticles prepared at pH 1 and pH 5. The release also showed a dual-phasic profile with an initial burst and after that a slower release period. The dexmedetomidine release conformed to zero order kinetics from microparticles prepared at water/alkoxide ratios between r = 6 and r = 35 (at pH 13). The release rate was the slowest from microparticles prepared with water alkoxide ratio 35. The bioavailability of dexmedetomidine in dogs showed that the release was sustained from silica gel microparticles as compared with a subcutaneously administered reference dose of 0.1 mg. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2795 / 2801
页数:7
相关论文
共 26 条
[1]  
Aantaa Riku, 1993, Drugs of the Future, V18, P49
[2]   Silica xerogel carrier material for controlled release of toremifene citrate [J].
Ahola, M ;
Kortesuo, P ;
Kangasniemi, I ;
Kiesvaara, J ;
Yli-Urpo, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :219-227
[3]  
AHOLA M, 1998, 24 ANN M SOC BIOM SA, P343
[4]   In vitro release of heparin from silica xerogels [J].
Ahola, MS ;
Säilynoja, ES ;
Raitavuo, MH ;
Vaahtio, MM ;
Salonen, JI ;
Yli-Urpo, AUO .
BIOMATERIALS, 2001, 22 (15) :2163-2170
[5]   PREPARATION OF BIODEGRADABLE POLY (+/-) LACTIDE MICROPARTICLES USING A SPRAY-DRYING TECHNIQUE [J].
BODMEIER, R ;
CHEN, HG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (11) :754-757
[6]   Sol-gel carrier systems for controlled drug delivery [J].
Böttcher, H ;
Slowik, P ;
Süss, W .
JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY, 1998, 13 (1-3) :277-281
[7]  
BRINKER CJ, 1990, PHYSICS CHEM SOL GEL
[8]   POLYMERIC MICROSPHERES AS DRUG CARRIERS [J].
DAVIS, SS ;
ILLUM, L .
BIOMATERIALS, 1988, 9 (01) :111-115
[9]  
Eisenach JC, 1994, EXPERT OPIN INV DRUG, V3, P1005
[10]   SURFACE FORCES AND THEIR ACTION IN CERAMIC MATERIALS [J].
HORN, RG .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1990, 73 (05) :1117-1135